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Aims To determine diagnostic accuracy, effective radiation dose, and potential value of computed tomography coronary
angiography (CTCA) for hybrid imaging with single-photon emission computed tomography (SPECT) comparing pro-
spective electrocardiogram (ECG)-triggering vs. retrospective ECG-gating.
Methods
and results
Two hundred patients underwent standard myocardial stress/rest- SPECT perfusion imaging, which served as stan-
dard of reference. One hundred consecutive patients underwent 64-slice CTCA using prospective ECG-gating, and
were compared with 100 patients who had previously undergone CTCA using retrospective ECG-gating. For predict-
ing ischaemia, CTCA with prospective ECG-triggering and a stenosis cut-off .50% had a per-vessel sensitivity, speci-
ficity, negative, and positive predictive value of 100, 84, 100, and 30%; respective values for CTCA with retrospective
ECG-gating were similar (P ¼ n.s.): 86, 83, 98, and 33%. Combining CTCA with stress-only SPECT revealed 100%
clinical agreement with regard to perfusion defects, and provided additional information in half the patients on pre-
clinical coronary findings. Effective radiation dose was 2.2+ 0.7 mSv for CTCA with prospective ECG-triggering, and
19.7+ 4.2 mSv with retrospective ECG-gating (P, 0.001) (5.4+0.8 vs. 24.1+ 4.3 mSv for hybrid imaging).
Conclusion Prospective ECG-triggering for CTCA reduces radiation dose by almost 90% without affecting diagnostic perform-
ance. Combined imaging with stress-only SPECT is an attractive alternative to standard stress/rest-SPECT for evalu-
ation of coronary artery disease, offering additional information on preclinical atherosclerosis.
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Introduction
In the past years computed tomography coronary angiography
(CTCA) had been used increasingly in the assessment of coronary
artery disease (CAD), as it offers high diagnostic accuracy in steno-
sis detection,1–4 short examination time, and minimal side effects
apart from the potential harm of radiation-induced neoplasms,
which has evoked a vivid controversy on the clinical benefit of
CTCA. This has induced the search for strategies to minimize
the radiation dose while maintaining image quality. Several techni-
cal advances have allowed to decrease the dose from originally
20–254 to 10–15 mSv by use of electrocardiogram (ECG)-gated
tube modulation5 and even below 10 mSv by further optimizing
scanning parameters of CTCA with retrospective ECG-gating.6 A
recent milestone for wide clinical acceptance of CTCA was the
introduction of prospective ECG-triggering, by which scanning is
limited to a narrow predefined end-diastolic phase resulting in a
massive reduction of radiation exposure to a range of 1–3 mSv.7
The validity of this new low-dose protocol has been confirmed
in a larger unselected patient population8 and preliminary
reports encourage the use of this protocol in latest generation
CT scanners with 320 slices.9 However, at present no data exist
on the performance of CTCA with retrospective ECG-gating
vs. CTCA with prospective ECG-triggering in comparison to a
standard of reference for ischaemia.
As objective proof of ischaemia is the main determinant for clini-
cal decision making in chronic stable CAD,10–12 we have used
myocardial perfusion imaging (MPI) with single-photon emission
computed tomography (SPECT) as standard of reference.
However, as CTCA visualizes coronary artery stenoses directly,
and MPI identifies ischaemia, both methods may also provide
complementary information on CAD,13 and hybrid examinations
may facilitate a comprehensive interpretation of coronary lesions
and their pathophysiological relevance.13–16 Effective radiation
doses for hybrid imaging with SPECT MPI and CTCA using retro-
spective ECG-gating of up to 41 mSv17 have been reported in the
literature, precluding its widespread clinical use, while prospective
ECG-triggering may overcome this drawback. A further decrease
in radiation dose of hybrid imaging could be achieved by confining
the SPECT scan to stress-only, as recently suggested for low
pre-test probability populations.18
Therefore, the purpose of the present study was two-fold: First,
to compare the diagnostic accuracy of CTCA with low-dose
prospective ECG-triggering vs. standard retrospective gating for
detecting haemodynamic relevant coronary lesions; and second,
to validate a new algorithm for evaluation of unknown CAD by
hybrid imaging combining CTCA with low-dose stress-only
SPECT; standard stress/rest-SPECT served as the standard of
reference for both aims.
Methods
Study design
Each patient underwent low-dose stress/high-dose rest-SPECT, and
CTCA for clinical indication.
First step: Findings from both CTCA acquisition protocols were
separately analysed and compared with SPECT results.
Second step: Two independent blinded readers analysed either
the paired stress-SPECT plus CTCA (CTCA/stress-SPECT) or the
stress-SPECT plus the rest-SPECT scan (stress/rest-SPECT).
Clinical study endpoints were, first, the direct comparison of total
effective radiation dose and diagnostic accuracy of both CTCA proto-
cols, and, second the comparison of hybrid CTCA/stress-SPECT vs.
standard stress/rest-SPECT with regard to: agreement on presence
or absence of ischaemic coronary heart disease, information on pre-
clinical CAD, total effective radiation dose, and total examination
duration.
Patient groups
One hundred consecutive patients with suspected (n ¼ 85) or known
(n ¼ 15) CAD referred for MPI with SPECT and CTCA using prospec-
tive ECG-triggering were prospectively enrolled in the present study, if
none of the following exclusion criteria were present: hypersensitivity
to iodinated contrast agent, renal insufficiency (creatinine levels
.150 mmol/L, or .1.7 mg/dL), non-sinus rhythm, or previous coron-
ary bypass surgery. These patients were compared with 100 retrospec-
tively enrolled patients, who had previously undergone MPI and CTCA
using retrospective ECG-gating; groups were matched for the pre-
sence of known CAD, heart rate, and body mass index (BMI). We
decided to include 100 patients into the final analysis of this prelimi-
nary report, although no formal sample size calculation was performed
due to the pilot nature of this study.
The study protocol was approved by the institutional review board
and written informed consent was obtained.
Computed tomography coronary
angiography data acquisition and
post-processing
All 200 patients received a single dose of 2.5 mg isosorbiddinitrate
sublingual (Isoket, Schwarz Pharma, Monheim, Germany) 2 min prior
to the scan. In addition, intravenous metoprolol (5–20 mg) (Beloc,
AstraZeneca, London, UK) was administered prior to the CTCA
examination if necessary to achieve a target heart rate ,65 b.p.m.
For CTCA, 80 mL of iodixanol (Visipaque 320, 320 mg/mL, GE Heath-
care, Buckinghamshire, UK) at a flow rate of 5 mL/s followed by 50 mL
saline solution was injected into an antecubital vein via an 18-gauge
catheter. Bolus tracking was performed with a region of interest
placed into the ascending aorta.
All CTCA examinations were performed on a LightSpeed VCT XT
scanner (GE Healthcare) using two different scanning protocols.
Prospective ECG-triggering: slice acquisition 64  0.625 mm, smallest
X-ray window (only 75% of the R–R interval; padding set to 0 ms),
z-coverage 40 mm with an increment of 35 mm, gantry rotation time
350 ms, BMI-adapted tube voltage (100–120 kV), and effective tube-
current (450–700 mA).
Retrospective ECG-gating: slice acquisition 64  0.625 mm, z-coverage
40 mm, heart rate adapted pitch ranging between 0.18 and 0.26, gantry
rotation time 350 ms, tube voltage 120 kV, BMI-adapted effective
tube-current (280–750 mA), and ECG-adapted tube modulation (i.e.
reduction to about 40% of nominal tube current during systole to
mid-diastole). Computed tomography data sets were retrospectively
reconstructed in mid- to end-diastolic phases and additional phases if
needed for optimal coronary artery visualization.
Computed tomography coronary angiography image quality was
assessed in all coronary segments19 of all patients using a previously
reported scoring system.20 If one or more segments in a patient
were rated ‘non-diagnostic’, then the examination was excluded
from further analysis (for retrospective ECG-gating an examination
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was excluded from further analysis, if at least one coronary segment
was considered ‘non-diagnostic’ in all reconstructed phases of the
R–R interval).
Single-photon emission computed
tomography data acquisition
and post-processing
Single-photon emission computed tomography data acquisition was
performed on a dual-head detector camera (Ventri, GE Healthcare,
Milwaukee, WI, USA), and all patients underwent a 1-day stress
(0.14 mg/kg/min adenosine i.v.)/rest MPI protocol using a dose of
300 and 900 MBq of 99mTc-tetrofosmin, respectively. Emission data
were acquired with a parallel-hole, low-energy, high-resolution colli-
mator with a 20% symmetric window centred at 140 keV. Further
acquisition parameters were 38 rotation per stop, 1808 each head,
and 25 s per projection. Acquisitions were gated for 16 frames per
R–R cycle with an acceptance window of 50%. All patients underwent
low-dose, unenhanced CT for attenuation correction on a LightSpeed
VCT XT scanner (GE Healthcare), as previously reported in detail.21
Diagnostic accuracy
Computed tomography coronary angiography images were evaluated
and classified by two independent readers, blinded to the results of
SPECT, using axial source images, multi-planar reformations, and thin-
slab maximum intensity projections. Coronary arteries were visually
assessed for the presence of narrowing of the coronary luminal diam-
eter .50 and .75%.
Single-photon emission computed tomography data were analysed,
blinded to the results of CTCA, with regard to the presence of revers-
ible and/or fixed perfusion defects on short-axis, horizontal and verti-
cal long-axes slices as well as on the polar maps. Left ventricular
perfusion defects were attributed to three vascular territories: left
anterior descending artery (LAD) included the apical, anterior, septal
wall; circumflex artery (CX) included the lateral wall; right coronary
artery (RCA) included the inferior wall.
Effective radiation dose
The total effective dose of CTCA was calculated as the product of the
dose–length product (DLP) times a conversion coefficient for the
chest (k ¼ 0.017 mSv/mGy  cm).5 For SPECT, the effective radiation
dose was estimated as previously suggested (6.7mSv/GBq)5 plus the
dose for CT attenuation correction (DLP  conversion coefficient
for the chest).
Duration of examination protocols
The routine time schedule for the standard stress/rest-SPECT proto-
col22 used at our institute requires a period of 90 min between each
injection of 99mTc-tetrofosmin and the following data acquisition.
Computed tomography coronary angiography is routinely performed
between the application of the tracer at stress and the first SPECT
data acquisition. For all patients the total time for both protocols
was assessed.
Statistical analysis
Quantitative variables were expressed as mean+standard deviation
and categorical variables as frequencies and percentages. Sensitivity,
specificity, positive predictive value (PPV), and negative predictive
value (NPV) were calculated, stress/rest MPI with SPECT was con-
sidered the standard of reference. Because of the interdependencies
between different vessels, the statistics were also calculated on a per-
patient basis (presence of at least one significant coronary artery
stenosis or absence of any significant stenosis in each patient). We
took into account the clustered nature of the data (i.e. the fact that
there were not 600 independent vessels but instead clusters of
vessels in 200 patients). For these analyses, a proportion-procedure
for survey data of the Stata software (Stata 10.0, StataCorp, College
Station, TX) with the patient as primary sample unit was performed
to address dependencies between the vessels.23 Differences between
the two matched patient populations regarding diagnostic performance
were tested for significance by using x2-tests for comparison of cross
tables. For further comparison, Mann–Whitney U-tests were per-
formed for: total effective radiation dose, heart rate, BMI, and age.
x2-tests were used to determine differences in gender, coronary risk
factors, clinical symptoms, and prevalence of known CAD. Differences
between CTCA/stress-SPECT and standard stress/rest-SPECT in total
radiation dose and total time between both protocols were deter-
mined using a paired Student’s t-test. A P-value of ,0.05 was con-
sidered to indicate statistical significance, all reported P-values were
two-sided and were not adjusted for multiple testing. SPSS software
(SPSS 15.0, Chicago, IL, USA) was used for statistical testing.
Results
The present study aimed at including 100 consecutive patients
scanned with prospective ECG-triggering (CAD) and a matched
control group scanned with retrospective ECG-gating. After
initial assessment, seven additional patients did not meet the
inclusion criteria because CTCA was not feasible due to non-sinus
rhythm (n ¼ 5), high heart rate despite beta-blocker administration
(n ¼ 1), and elevated creatinine levels (n ¼ 1). Of these resulting
100 initially included patients, 15 patients had to be excluded
because of non-diagnostic CTCA image quality in at least one cor-
onary segment, due to breathing (n ¼ 5) or motion artefacts (n ¼
10). The control group was retrospectively recruited from a large
pool of patients who had undergone CTCA with retrospective
ECG-gating. We identified 193 patients who had undergone
SPECT in addition to CTCA, of these, 100 patients were selected
who showed the best match with regard to presence of known
CAD, BMI, and heart rate. Of these resulting 100 initially included
patients, 13 patients were excluded because of breathing artefacts
(n ¼ 6), occurrence of a premature ventricular beat during scan-
ning (n ¼ 1), or coronary motion artefacts (n ¼ 6). Demographics
of the final two patient populations are given in Table 1.
Diagnostic accuracy
Prospective ECG-triggering: CTCA revealed 58 coronary vessels
(23%) with stenoses .50% in 29 of 85 patients (34%), and 18
vessels (7%) with stenoses .75% in 12 patients (14%). In this
group, MPI with SPECT detected perfusion defects in 20 vascular
territories (8%) of 18 patients (21%); while 5 of the defects
were fixed (scar) 11 were reversible (ischaemia), and 2 were
partly fixed and partly reversible (mixed defects).
Retrospective ECG-gating: Sixty-two coronary vessels (24%) with
stenoses .50% in 38 of 87 patients (44%), and 24 vessels (9%)
with stenoses .75% in 17 patients (20%) were observed on
CTCA scans. Perfusion defects in 27 (10%) vascular territories of
23 patients (26%) were detected by MPI with SPECT, i.e. 8 fixed,
15 reversible, and 4 mixed defects.
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The diagnostic performance of CTCA by prospective ECG-
triggering was comparable with retrospective ECG-gating
(Table 2); no statistically significant differences were detected.
Regardless of the scanning technique, CTCA is more sensitive
and offers a higher NPV for a stenosis cut-off .50% compared
with .75%. Conversely, sensitivity and NPV decrease, while speci-
ficity and the PPV increase when a cut-off .75% is chosen.
Hybrid imaging
Computed tomography coronary angiography/stress-SPECT with pro-
spective ECG-triggering identified the same 18 patients to have
abnormal perfusion, as the standard stress/rest-SPECT protocol,
resulting in a clinical agreement of 100% (Figure 1). Computed tom-
ography coronary angiography provided additional information in
38/85 patients (45%), i.e. intermediate coronary lesions (n ¼ 22),
non-stenosing coronary plaque (n ¼ 15), and coronary anomaly
(n ¼ 1) (Figure 2).
Computed tomography coronary angiography/stress-SPECT with
retrospective ECG-gating identified the same 23 patients to have
abnormal perfusion, as the standard stress/rest-SPECT protocol,
also resulting in a clinical agreement of 100%. Computed tomo-
graphy coronary angiography provided additional information in
43/87 patients (49%), i.e. intermediate coronary lesions (n ¼ 20),
non-stenosing coronary plaque (n ¼ 22), and coronary anomaly
(n ¼ 1).
The time schedule of the CTCA/stress-SPECT examination pro-
tocol was shorter as compared with standard stress/rest SPECT
(130 vs. 245 min, P, 0.001), as all CTCA examinations (either
with prospective ECG-triggering or with retrospective ECG-
gating) were performed in the 90 min between the first injection
of 99mTc-tetrofosmin and stress data acquisition.
Total effective radiation dose
The mean total effective radiation dose of CTCA with prospective
ECG-triggering was 2.2+0.7 mSv (range: 1.0–3.3 mSv), repre-
senting a reduction of about 90% when compared with the
19.7+ 4.2 mSv (range: 11.5–33.0 mSv) obtained with retrospec-
tive ECG-gating (P, 0.001).
Radiation exposure from SPECT was—by definition of the study
design—comparable in both groups: i.e. 9.6+0.7 mSv (range: 8.2–
12.5 mSv) in the prospectively triggered group, and 10.7+1.1 mSv
(range: 8.5–14.4 mSv) in the group with retrospective ECG-gating.
Combining stress-only SPECT with prospective ECG-triggering
allows a significant reduction of total effective radiation dose,
when compared with hybrid imaging with retrospective ECG-
gating (5.4+0.8 vs. 24.1+4.3 mSv, P, 0.001).
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Table 1 Patient demographics
Retrospective
electrocardiogram-gating
Prospective
electrocardiogram-triggering
P-value
Enrolled patients 100 100
Inadequate computed tomography coronary
angiography quality
13 15 0.68
Final study population 87 85
Female/male 30/57 30/55 0.91
Age (years) 63+11 (33–89) 59+11 (27–85) 0.04a
BMI (kg/m2) 27+4 (19–50) 27+4 (18–39) 0.43
Heart rate (b.p.m.) 58+6 (45–73) 57+6 (40–70) 0.12
Known coronary artery disease, (%) 11 (13) 12 (14) 0.78
Previous infarction, (%) 5 (6) 3 (4) 0.49
Previous stent placement, (%) 7 (8) 6 (7) 0.32
Coronary risk factors, (%)
Smokers 24 (28) 35 (41) 0.06
Hypertension 56 (64) 50 (59) 0.46
Diabetes 11 (13) 11 (13) 0.95
Positive family history 22 (25) 29 (34) 0.21
Dyslipidaemia 41 (47) 43 (51) 0.65
Clinical symptoms, (%)
None 35 (40) 21 (25) 0.03a
Typical angina 23 (26) 16 (19) 0.23
Atypical chest pain 22 (25) 38 (45) 0.003a
Dyspnoea 11 (13) 10 (12) 0.86
aIndicates statistical significance.
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Table 2 Diagnostic accuracy of computed tomography coronary angiography
All patients Retrospective electrocardiogram-gating Prospective electrocardiogram-triggering
Any perfusion defect Reversible defects only Any perfusion defect Reversible defects only
>50% >75% >50% >75% >50% >75% >50% >75%
Patient-based
Sens. % (CI;n) 91 (79–100;21/23) 57 (36–77;13/23) 89 (75–100;17/19) 53 (29–76;10/19) 94 (83–100;17/18) 61 (38–84;11/18) 100 (NA;13/13) 71 (47–96;10/14)
Spec. % (CI;n) 73 (62–84;47/64) 94 (88–100;60/64) 73 (62–84;47/64) 94 (88–100;60/64) 76 (66–86;51/67) 97 (93–100;65/67) 76 (66–86;51/66) 97 (93–100;65/67)
NPV % (CI;n) 96 (90–100;47/49) 86 (77–94;60/70) 96 (90–100;47/49) 87 (79–95;60/69) 98 (94–100;51/52) 90 (83–97;65/72) 100 (NA;51/51) 94 (88–100;65/69)
PPV % (CI;n) 55 (39–71;21/38) 77 (56–97;13/17) 50 (33–67;17/34) 71 (47–96;10/14) 52 (34–69;17/33) 85 (64–100;11/13) 47 (28–65;13/28) 83 (61–100;10/12)
Vessel-based
Sens. % (CI;n) 85 (72–99;23/27) 59 (41–77;16/27) 86 (71–100;19/22) 59 (39–79;13/22) 85 (69–100;17/20) 65 (42–‘88;13/20) 100 (NA;16/16) 75 (52–98;12/16)
Spec. % (CI;n) 83 (77–90;195/234) 97 (93–100;226/234) 83 (77–90;189/227) 96 (93–100;219/227) 83 (76–89;194/235) 98 (95–100;230/235) 84 (77–90;190/227) 98 (95–100;223/227)
NPV % (CI;n) 98 (96–100;195/199) 95 (93–98;226/237) 98 (97–100;189/192) 96 (94–99;219/228) 98 (97–100;194/197) 97 (95–99;230/237) 100 (NA;190/190) 98 (97–100;223/227)
PPV % (CI;n) 37 (23–51;23/62) 67 (43–90;16/24) 33 (19–48;19/57) 62 (36–88;13/21) 29 (17–42;17/58) 72 (43–100;13/18) 30 (16–44;16/53) 75 (43–100;12/16)
Unknown coronary artery disease only
Patient-based
Sens. % (CI;n) 87 (69–100;13/15) 53 (27–80;8/15) 83 (61–100;10/12) 50 (20–80;6/12) 92 (75–100;11/12) 75 (49–100;9/12) 100 (NA;9/9) 80 (54–100;8/10)
Spec. % (CI;n) 74 (63–85;45/61) 95 (90–100;58/61) 74 (63–85;45/61) 95 (90–100;58/61) 79 (68–89;48/61) 97 (92–100;59/61) 79 (68–89;48/60) 97 (92–100;59/61)
NPV % (CI;n) 96 (90–100;45/47) 89 (82–97;58/65) 96 (90–100;45/47) 91 (83–98;58/64) 98 (94–100;48/49) 95 (90–100;59/62) 100 (NA;48/48) 97 (92–100; 59/61)
PPV % (CI;n) 45 (26–63;13/29) 73 (45–100;8/11) 39 (19–58;10/26) 67 (38–100;6/9) 46 (25–66;11/24) 82 (58–100;9/11) 43 (23–64;9/21) 80 (54–100;8/10)
Vessel-based
Sens. % (CI;n) 88 (70–100;14/16) 63 (37–88;10/16) 85 (64–100;11/13) 62 (33–90;8/13) 93 (79–100;13/14) 79 (55–100;11/14) 100 (NA;12/12) 83 (61–100;10/12)
Spec. % (CI;n) 84 (78–91;179/212) 97 (94–100;206/212) 84 (78–91;174/206) 97 (94–100;200/206) 85 (78–92;174/205) 98 (94–100;200/205) 86 (79–93;172/201) 98 (95–100;197/201)
NPV % (CI;n) 99 (97–100;179/181) 97 (95–99;206/212) 99 (97–100;174/176) 98 (95–100;200/205) 99 (98–99;174/175) 99 (97–100;200/203) 100 (NA;172/172) 99 (98–100;197/199)
PPV % (CI;n) 30 (15–40;14/47) 63 (34–91;10/16) 26 (11–40;11/43) 57 (26–88;8/14) 30 (14–45;31/44) 69 (37–100;11/16) 29 (13–46;12/41) 71 (35–100;10/14)
CI, 95% confidence interval; n, absolute numbers; Sens., sensitivity; Spec., specificity; NA, not available; NPV, negative predictive value; PPV, positive predictive value.
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Discussion
The main findings of the present study are two-fold: first, it
documents that prospective ECG-triggering provides an excellent
diagnostic accuracy, comparable with retrospective ECG-gating,
despite a decrease in radiation dose by about 90%. Second, we
have validated a new low-dose hybrid SPECT/CTCA algorithm
for assessment of CAD allowing reduction in protocol time as
well as in radiation dose at maintained accuracy compared with
stress/rest SPECT offering additional clinical information.
Conventional spiral CTCA protocols using retrospective ECG-
gating have been shown to be associated with high total radiation
doses between 9.4 and 21.4 mSv.4,24 With the introduction of pro-
spective ECG-gating, however, the total radiation dose of CTCA
could be reduced down to 2.1 mSv.7 Only one study25 has directly
compared total effective radiation doses of the two protocols in a
head-to-head comparison, describing a 79% decrease from CTCA
with retrospective ECG-gating (20.0 mSv) to CTCA with prospec-
tive ECG-triggering (4.1 mSv), which is very similar to the results in
the two matched patient populations of the present study (i.e. 2.2
and 19.7 mSv).
Our study provides evidence that accuracy of CTCA is pre-
served even after introducing the prospective ECG-triggering pro-
tocol. No data exists on direct comparison between the two
protocols with regard to diagnostic performance, although prelimi-
nary data have proved the feasibility and documented preserved
image quality with the new dose saving protocol.7,8,25,26 The
present data not only confirm the substantial reduction in effective
radiation dose, but also document that the accuracy of CTCA with
prospective ECG-triggering equals the accuracy of retrospectively
gated CTCA. As the reduction in radiation dose is striking, the
widespread use of prospective ECG-gating may now be envisaged.
Our results display an excellent NPV but a modest PPV in the
detection of ischaemic heart disease, especially when a cut-off
for luminal narrowing is chosen at 50%. This is in line with previous
results,27–29 and concurs with the generally accepted fact that the
strengths of CTCA lies in its excellent ability to rule out CAD. As a
consequence most recommendations consider the use of CTCA
mainly in low-to-intermediate risk populations,30 in which event
rate and mortality are low and unlikely to be further lowered by
any diagnostic or therapeutic procedure. Therefore the bars are
very high for any diagnostic tool to keep a positive balance
between harms and benefits. This is reflected by the ongoing con-
troversy on the potential carcinogenic risk of the effective radiation
dose and its justification for a purely diagnostic application. In this
context, prospective ECG-triggering represents a milestone as it
allows accurate CAD assessment with low-dose CTCA, which
appears to be an ideal ‘gate-keeper’ for the assessment of
unknown CAD in selected patient populations (i.e.
low-to-intermediate pre-test probability) due to its high NPV,
and may offer an alternative to SPECT. Computed tomography
coronary angiography is less expensive and the examination time
is shorter when compared with MPI with SPECT, although new
multi-headed SPECT systems may allow considerable shortening
of scan duration.
In clinical routine, standard stress/rest SPECT MPI scans are
important to determine the reversibility of perfusion defects in
patients with a history of myocardial infarction.22 In contrast, in a
patient population with low-to-intermediate pre-test probability
and unknown CAD, the aim of any test is to reveal the presence
of CAD, while potential discrimination of scar from ischaemia
Figure 2 Fused stress 99mTc-tetrofosmin perfusion single-
photon emission computed tomography/computed tomography
coronary angiography image (radiation dose from computed tom-
ography coronary angiography 1.3 mSv, from stress-single-photon
emission computed tomography 2.2 mSv) reveals normal myocar-
dial perfusion, but non-significant vessel wall irregularities in the
proximal left anterior descending artery (arrows heads), as well
as a coronary anomaly (arrow; origin of the right coronary artery
from the left coronary sinus).
Figure 1 Fused stress 99mTc-tetrofosmin perfusion single-
photon emission computed tomography/computed tomography
coronary angiography image (radiation dose from computed tom-
ography coronary angiography 2.2 mSv, from stress-single-photon
emission computed tomography 2.5 mSv), showing a lateral per-
fusion defect (arrows heads), served by the stented circumflex
artery. Sequential intermediate lesions in the left anterior descend-
ing artery (arrows) are not haemodynamically relevant (no per-
fusion defect).
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remains beyond the primary focus of the examination. In patients
with normal myocardial perfusion at stress, however, subclinical,
yet prognostically relevant31 CAD may be present and patients
may benefit from risk factor modification or even specific treat-
ment for CAD.32 The present study demonstrates that low dose
CTCA/stress-SPECT offers such additional information on pre-
clinical CAD in a large proportion of patients at no cost of
additional radiation exposure. Furthermore, hybrid cardiac
imaging offers a high confidence in image interpretation as the
occurrence of equivocal findings in one modality may be sup-
plemented by the other.33 This seems to be particularly important
when CTCA is acquired with the prospective ECG-gating, as the
performance of this new technique may be prone to artefacts,
especially at higher heart rates.7
We acknowledge the following limitations to our study. After
the matching of two patient cohorts, several patients had to be
excluded from further analysis because of non-diagnostic image
quality in CTCA. This however, applies to both study groups,
which therefore remained well matched with regard to heart
rate and BMI or presence of known CAD. Furthermore, we
have included patients with known CAD, although our CTCA/
stress-SPECT algorithm appears most suitable for the assessment
of patients with unknown CAD, and does not allow distinguishing
reversible (ischaemia) from fixed defects (scar). Nevertheless,
these patients were included for validation purposes to ascertain
true positive findings and allow meaningful analysis. We did not
determine whether a pathological CTCA/stress-SPECT finding
should be completed by a rest-scan or directly by invasive coron-
ary angiography, as this decision would probably be best driven by
clinical context.
The use of prospective ECG-triggering for CTCA allows
reduction of radiation dose by almost 90% without affecting diag-
nostic performance. Hybrid imaging combining CTCA with
stress-only SPECT is an attractive alternative to standard stress/
rest SPECT for the detection of CAD, offering additional infor-
mation on pre-clinical atherosclerosis.
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